Pages that link to "Q43812676"
Jump to navigation
Jump to search
The following pages link to Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex (Q43812676):
Displayed 50 items.
- Future pharmacological treatments for substance use disorders (Q22242633) (← links)
- The dopamine theory of addiction: 40 years of highs and lows (Q22251015) (← links)
- Addiction science: Uncovering neurobiological complexity (Q22251251) (← links)
- NeuroAIDS, drug abuse, and inflammation: building collaborative research activities (Q23915009) (← links)
- Is cognitive functioning impaired in methamphetamine users? A critical review (Q24606455) (← links)
- Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals (Q24615244) (← links)
- Neurologic manifestations of chronic methamphetamine abuse (Q24624506) (← links)
- Neuroimaging and drug taking in primates (Q24631230) (← links)
- Methamphetamine-associated psychosis (Q24632172) (← links)
- Neurocircuitry of addiction (Q24647156) (← links)
- Neural substrates of cognitive inflexibility after chronic cocaine exposure (Q24648658) (← links)
- Pharmacotherapy of methamphetamine addiction: an update (Q24648913) (← links)
- Potential adverse effects of amphetamine treatment on brain and behavior: a review (Q24657966) (← links)
- Impaired time perception and motor timing in stimulant-dependent subjects (Q24679730) (← links)
- A meta-analysis of the relationship between brain dopamine receptors and obesity: a matter of changes in behavior rather than food addiction? (Q26752845) (← links)
- Fischer 344 and Lewis Rat Strains as a Model of Genetic Vulnerability to Drug Addiction (Q26768236) (← links)
- Effects of anabolic-androgens on brain reward function (Q26785394) (← links)
- The Brain on Drugs: From Reward to Addiction (Q26798096) (← links)
- Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications (Q26823158) (← links)
- Obesity and addiction: neurobiological overlaps (Q26827446) (← links)
- Positron emission tomography molecular imaging of dopaminergic system in drug addiction (Q26992051) (← links)
- Addicted to palatable foods: comparing the neurobiology of Bulimia Nervosa to that of drug addiction (Q26996271) (← links)
- Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction (Q27014154) (← links)
- Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development (Q27014737) (← links)
- Neuroimaging for drug addiction and related behaviors (Q27014859) (← links)
- Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder (Q27015917) (← links)
- Differential effects of the dopamine D3 receptor antagonist PG01037 on cocaine and methamphetamine self-administration in rhesus monkeys (Q27305163) (← links)
- Chronic cocaine disrupts mesocortical learning mechanisms (Q28081785) (← links)
- The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans (Q28236333) (← links)
- Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction (Q28287764) (← links)
- Substituted methcathinones differ in transporter and receptor interactions (Q28288908) (← links)
- Treadmill exercise improves fitness and reduces craving and use of cocaine in individuals with concurrent cocaine and tobacco-use disorder (Q28391787) (← links)
- Altered ratio of D1 and D2 dopamine receptors in mouse striatum is associated with behavioral sensitization to cocaine (Q28474330) (← links)
- Illicit stimulant use is associated with abnormal substantia nigra morphology in humans (Q28486143) (← links)
- Methamphetamine accelerates cellular senescence through stimulation of de novo ceramide biosynthesis (Q28543389) (← links)
- Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users (Q28551943) (← links)
- Dysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure (Q28729938) (← links)
- Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors (Q28731615) (← links)
- Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex (Q29619998) (← links)
- Pharmacotherapeutic agents in the treatment of methamphetamine dependence. (Q30235058) (← links)
- HIV-1 Proteins Influence Novelty-Seeking Behavior and Alter Region-Specific Transcriptional Responses to Chronic Nicotine Treatment in HIV-1Tg Rats (Q30252876) (← links)
- Addiction is Not a Natural Kind (Q30354281) (← links)
- Neonatal +-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists (Q30401457) (← links)
- Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior (Q30413183) (← links)
- Monoamine transporter inhibitors and substrates as treatments for stimulant abuse (Q30413718) (← links)
- Connecting the pathology of posttraumatic stress and substance use disorders: monoamines and neuropeptides (Q30419977) (← links)
- Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity (Q30422045) (← links)
- Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective (Q30492329) (← links)
- Behavioral genetic contributions to the study of addiction-related amphetamine effects (Q30494693) (← links)
- Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. (Q30498096) (← links)